Form 8-K - Current report:
SEC Accession No. 0001104659-24-122027
Filing Date
2024-11-22
Accepted
2024-11-22 14:28:06
Documents
17
Period of Report
2024-11-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2429161d1_8k.htm   iXBRL 8-K 41305
2 EXHIBIT 3.1 tm2429161d1_ex3-1.htm EX-3.1 111709
3 EXHIBIT 99.1 tm2429161d1_ex99-1.htm EX-99.1 10653
8 GRAPHIC tm2429161d1_ex99-1img001.jpg GRAPHIC 4146
  Complete submission text file 0001104659-24-122027.txt   453705

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrk-20241119.xsd EX-101.SCH 4656
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20241119_def.xml EX-101.DEF 29175
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20241119_lab.xml EX-101.LAB 39689
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20241119_pre.xml EX-101.PRE 27659
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2429161d1_8k_htm.xml XML 11440
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 241488930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)